ID: ALA3961306

Max Phase: Preclinical

Molecular Formula: C15H14Cl2FNO5

Molecular Weight: 378.18

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N[C@]1(C(=O)O)[C@@H]2[C@@H](C(=O)O)[C@@H]2[C@H](F)[C@H]1OCc1ccc(Cl)c(Cl)c1

Standard InChI:  InChI=1S/C15H14Cl2FNO5/c16-6-2-1-5(3-7(6)17)4-24-12-11(18)8-9(13(20)21)10(8)15(12,19)14(22)23/h1-3,8-12H,4,19H2,(H,20,21)(H,22,23)/t8-,9-,10-,11-,12+,15+/m0/s1

Standard InChI Key:  UDWSIQSDTWFRQU-ANYOLZDRSA-N

Associated Targets(Human)

Metabotropic glutamate receptor 3 732 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Metabotropic glutamate receptor 2 3206 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 378.18Molecular Weight (Monoisotopic): 377.0233AlogP: 1.96#Rotatable Bonds: 5
Polar Surface Area: 109.85Molecular Species: ZWITTERIONHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 1.69CX Basic pKa: 9.16CX LogP: -0.52CX LogD: -3.64
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.72Np Likeness Score: 0.24

References

1. Dressman BA, Tromiczak EG, Chappell MD, Tripp AE, Quimby SJ, Vetman T, Fivush AM, Matt J, Jaramillo C, Li R, Khilevich A, Blanco MJ, Smith SC, Carpintero M, de Diego JE, Barberis M, García-Cerrada S, Soriano JF, Schkeryantz JM, Witkin JM, Wafford KA, Seidel W, Britton T, Overshiner CD, Li X, Wang XS, Heinz BA, Catlow JT, Swanson S, Bedwell D, Ornstein PL, Mitch CH..  (2016)  Novel bicyclo[3.1.0]hexane analogs as antagonists of metabotropic glutamate 2/3 receptors for the treatment of depression.,  26  (23): [PMID:27836401] [10.1016/j.bmcl.2016.10.067]

Source